Financhill
Back

Meituan Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
43

MPNGF
Meituan

Last Price:
20.59
Seasonality Move:
-4.68%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.92
Seasonality Move:
14.88%
Sell
43
Meituan (MPNGF) is a Sell

Is Meituan a Buy, Sell or Hold?

  • The current Meituan [MPNGF] share price is $20.59. The Score for MPNGF is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • MPNGF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MPNGF Stock Price Chart

What is Meituan's stock price today?

  • The Meituan share price today is $20.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MPNGF is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

MPNGF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 42.35 Sell
Chaikin Money Flow: -186 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.48 - 24.22) Sell
Bollinger Bands (100): (13.67 - 22.81) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

MPNGF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.28 Sell
20-day SMA: 22.5 Sell
50-day SMA: 22.3 Sell
200-day SMA: 15.68 Buy
8-day EMA: 21.27 Sell
20-day EMA: 22.05 Sell
50-day EMA: 21.37 Sell
200-day EMA: 17.22 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Meituan Earnings Growth & MPNGF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Meituan Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):